Q/C Technologies,…
USUSDQ/C Technologies, Inc. (US:QCLS) — Biotechnology: In Vitro & In Vivo Diagnostic Substances. Numărul de burse pe care se tranzacționează acțiunile companiei: 2. Pe această pagină — preț și grafic, dividende, principalii deținători și istoricul numărului de acțiuni.
Despre Companie
- Site Web
- ir.qctechnologies.com
- Relații cu Investitorii
- ir.qctechnologies.com/news-events/ir-calendar
- Sector
- Health Care · Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sediu Central
- NEW YORK, United States
- Angajați
- 3
- Acțiuni în Circulație
- 8.19 mil. la 2026-08-12
- Free Float
- 7.9 mil.
- Capitalizare de Piață
- 5.16 mil. USD
- Insideri
- 7.53%
- Investitori Instituționali
- 9.02%
- Industrie (SIC)
- In Vitro & In Vivo Diagnostic Substances
- FCF
- —
- Datorie
- 3.53 mil. USD
- Câștiguri și FCF — pentru cele 12 luni până la 30.06.2026 (cel mai recent raport al companiei).
- NAV
Descriere
Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company. It operates through Pharmaceuticals and Computing Technology segments. The company develops Isomyosamine, a clinical stage small molecule that regulates the immunometabolic system to treat autoimmune disease, including sarcopenia, frailty, adverse effects of drugs used to treat diabetes and obesity, rheumatoid arthritis, and inflammatory bowel disease. It also develops Supera-CBD, a synthetic analog derivative of cannabidiol (CBD) to treat various conditions, including epilepsy, pain and anxiety/depression. In addition, it is involved in the development and eventual application of quantum computing technology, both for cryptocurrency applications;. The company was formerly known as TNF Pharmaceuticals, Inc. and changed its name to Q/C Technologies, Inc. in September 2025. The company was founded in 2014 and is headquartered in New York, New York.
Cei Mai Mari Acționari
| Deținător | Participație | Acțiuni | Data Raportului |
|---|---|---|---|
| Quinn Opportunity Partne… | 1.5% | 123 024 | 2026-06-30 |
| Vanguard Capital Managem… | 1.4% | 115 031 | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 1.4% | 115 031 | 2026-06-30 |
| Jane Street Group, LLC | 1.07% | 87 241 | 2026-06-30 |
| Geode Capital Management… | 0.86% | 70 682 | 2026-06-30 |
| UBS Group AG | 0.72% | 58 894 | 2026-06-30 |
| Balyasny Asset Managemen… | 0.7% | 57 692 | 2026-06-30 |
| HRT Financial LP | 0.62% | 50 373 | 2026-06-30 |
| Adar1 Capital Management… | 0.61% | 50 000 | 2026-06-30 |
| Vanguard Fiduciary Trust… | 0.53% | 43 053 | 2026-06-30 |
| Fidelity Concord Street… | 0.5% | 41 099 | 2026-07-31 |
| State Street Corporation | 0.31% | 25 305 | 2026-06-30 |
| WHITE BILLY JOE (Directo… | ≈0.31% | 25 024 | 2025-11-14 |
| BERNSTEIN BRUCE G (Direc… | ≈0.3% | 25 000 | 2025-11-14 |
| FRISCIA STEPHEN (Directo… | ≈0.3% | 25 000 | 2025-11-14 |
| DFA INVESTMENT DIMENSION… | 0.16% | 13 189 | 2026-07-31 |
| Fidelity Concord Street… | 0.16% | 12 992 | 2026-07-31 |
| GLASS MITCHELL (Officer… | ≈0.15% | 12 500 | 2025-11-14 |
| RAUCH GARY M (Divisional… | ≈0.15% | 12 500 | 2025-11-14 |
| Fidelity Concord Street… | 0.13% | 10 454 | 2026-07-31 |
| Fidelity Concord Street… | 0.07% | 5 674 | 2026-07-31 |
| Dimensional ETF Trust-Di… | 0.07% | 5 569 | 2026-07-31 |
| Dimensional ETF Trust-Di… | 0% | 300 | 2026-07-31 |
| John Hancock Variable In… | 0% | 194 | 2026-06-30 |
| VOSS CHELSEA SIERRA (Dir… | — | — | 2026-03-30 |
Conectează-te cu Google